PLoS Pathogens (Dec 2020)
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.
Abstract
[This corrects the article DOI: 10.1371/journal.ppat.1008477.].
PLoS Pathogens (Dec 2020)
[This corrects the article DOI: 10.1371/journal.ppat.1008477.].